Low- versus high-dose thalidomide in patients with advanced multiple myeloma

Trial Profile

Low- versus high-dose thalidomide in patients with advanced multiple myeloma

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Mar 2012

At a glance

  • Drugs Dexamethasone; Thalidomide
  • Indications Multiple myeloma
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Mar 2012 Results published in the European Journal of Haematology.
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top